PS198. Presentation, Management and Outcome of Femoral Anastomotic Pseudoaneurysms in the Era of Endovascular Interventions  by Kakkos, Stavros K. et al.
ce,
ive
t,
e,
sis,
on
e,
sis
e,
1
1
JOURNAL OF VASCULAR SURGERY
June Supplement 201070S AbstractsResults: In the 96 patient study, mean effective dose
for EVAR was 12.6mSv (.23 - 80.9), and mean FT was
18.8mins (.2 - 64.6). Phantom studies determined patient
entrance dose for selected FOV (36, 28, 20 and 14cm) as
3.65, 5.32, 8.46 and 15.6mGy/min for Flouroscopy and
1.1, 1.94, 3.15 and 3.83mGy/frame for DSA. The 7
patient study showed mean number of digital frames was
191 (100 - 376) and maximum calculated skin dose was
1.3Gy, below deterministic injury threshold. Stochastic risk
for EVAR and associated CT was  1/800.
Conclusions:Our data confirms a significant variation in
radiation exposure during EVAR. We have combined clinical
and phantom data to calculate the radiation dose per individ-
ual step. This has the potential to be used as an educational
tool and to support optimization and dose reduction.
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Objectives: To evaluate our results when we employed
an ultrasound debridment system to treat infected grafts.
Methods: Patients with poor medical conditions and
those with unavailable autogenous grafts underwent an
accurate debridement of the grafts and surrounding tissue
with an ultrasonic debridement machinery. Complete graft
removal and Sartorius flap to cover the inguinal region were
selectively employed. We used a powerful ultrasonic gener-
ator (Genera, Italia Medica, Milan, Italy) which operates
activating a probe mounted on a piezoelectric transducer.
The probe vibrates at 26 KHz with a vibratory amplitude of
15-30 m and it is irrigated with normal saline. The probe
generates mechanical-vibratory and cavitational energy
which allow a complete debridement of the necrotic and
infected tissue. The caloric energy developed implements
the killing bacteria effect of the formers.
Results: 11 patients (median age 67 years) with a
prosthetic vascular graft infection (early in 9 cases and a late
in 2) received an extensive US debridement to allow the
lower invasive reconstruction to be performed (i.e. in situ vs
extra-anatomic). Estimated freedom from recurrent infec-
tion was 90, 1% at 6 months and 75, 8% at 1 and 2 years.
Conclusions: In our experience US debridement of in-
fected grafts obtained promising results. This allowed us to treat
patients more conservatively without compromising the chance
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Volume 51, Number 11S Abstracts 71SObjectives: The contemporary use of endovascular tech-
niques has progressively limited the role of bypass grafting. As
a result of this paradigm shift and improvement in graft
materials, long-term complications like femoral anastomotic
pseudoaneurysms (FAPs)may be less frequently encountered,
resulting in limited exposure to present-day trainees. The aim
of this study was to investigate changes in the incidence and
outcome of FAPs.
Methods: Over a 20-year period (1987-2006 inclusive),
90 patients (61 males) underwent 120 operations to repair
125 FAPs. All but four of these aneurysms occurred after
aortofemoral grafting. Most patients presented with an iso-
lated pulsatile groin mass; three presented with acute expan-
sion/rupture. Prosthetic interposition graft repair was per-
formed in 97.4% and primary repair in the remainder.
Results: The number of repairs steadily declined over
the study period with the number of repairs performed
during the study’s consecutive quarters being 54, 41, 19
and 6, respectively). Morbidity did not change over the
course of the study and averaged 33%, but mortality did
decrease from 5.3% during the first decade to 0% during
the second decade (p 0.58). Demographics, associated
risk factors and diseases did not influence the above
outcomes. Five-year reoperation-free rate for FAP recur-
rence was 98% for primary repair or PTFE grafting and
85% for Dacron grafting (p  0.057); postoperative
wound complications did not affect these rates. Five and
ten-year patient survival was 55% and 34%, respectively.
Multivariate analysis with Cox regression identified
chronic renal failure and COPD as independent predic-
tors of worse long-term survival (relative risks, 3.6 and 3,
and p values, 0.001 and 0.001, respectively).
Conclusions: Although performed less frequently,
FAP repair is still associated with considerable morbidity.
Compared to Dacron, PTFE interposition graft repair is
associated with a reduced recurrence rate.
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Objectives: Post discharge outcomes are seldom in-
cluded in hospital quality reporting systems. Using the NS-
QIP database we analyzed risk factors related to inpatient vs
outpatient death as well as the time distribution of 30-day
mortality.Methods: We queried the ACS-NSQIP data set from
2005 to 2008 for vascular surgery using CPT and ICD-9
codes. Primary outcomes analyzed were postoperative
in-hospital and post-discharge death. Adjusted odds ra-
tios (OR) for timing and location of death were calcu-
lated by procedure, diagnosis as well as preoperative and
intraoperative risk factors.
Results:Our query resulted in 73, 833 vascular surgery
patients. 25% of deaths occurred after discharge. Overall,
preoperative risk factors predictive of post discharge mor-
tality were creatinine1.2 (OR 1.7), COPD (OR 1.3),
steroid treatment (OR 1.7) and dependent functional sta-
tus (OR 2.7). The timing of in-hospital vs post discharge
death is shown in the figure. Lower extremity amputation
was the only procedure with significantly higher risk of
death after discharge (OR 1.6).
Conclusions: In the 30-day postoperative period after
vascular surgery 1/4th of deaths occurs after discharge; it is
unclear whether this is a result of premature discharge. In-
hospitalmortality as a performancemeasuremay be unreliable
in view of our findings. We identified factors that correspond
to higher risk of post discharge mortality; recognition of
patients with this risk profile, appropriate management of
discharge planning and follow-up care may lead in reduction
of death rate after discharge.
Distribution of 30-day mortality
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